Compare RS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RS | SNN |
|---|---|---|
| Founded | 1939 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 14.3B |
| IPO Year | 1996 | N/A |
| Metric | RS | SNN |
|---|---|---|
| Price | $360.50 | $30.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $358.00 | $36.25 |
| AVG Volume (30 Days) | 281.7K | ★ 1.2M |
| Earning Date | 04-22-2026 | 03-16-2026 |
| Dividend Yield | 1.39% | ★ 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.10 | N/A |
| Revenue | ★ $14,805,900,000.00 | N/A |
| Revenue This Year | $10.16 | $8.58 |
| Revenue Next Year | $0.82 | $5.60 |
| P/E Ratio | $72.31 | ★ $64.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $260.31 | $28.23 |
| 52 Week High | $381.00 | $38.79 |
| Indicator | RS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 39.08 |
| Support Level | $284.23 | N/A |
| Resistance Level | $365.59 | $33.89 |
| Average True Range (ATR) | 9.86 | 0.61 |
| MACD | -0.48 | -0.18 |
| Stochastic Oscillator | 52.29 | 28.34 |
Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.